Form 8-K - Current report:
SEC Accession No. 0001193125-23-064549
Filing Date
2023-03-08
Accepted
2023-03-08 16:22:03
Documents
12
Period of Report
2023-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d479466d8k.htm   iXBRL 8-K 25011
  Complete submission text file 0001193125-23-064549.txt   143118

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA plrx-20230306.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20230306_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20230306_pre.xml EX-101.PRE 10814
6 EXTRACTED XBRL INSTANCE DOCUMENT d479466d8k_htm.xml XML 3245
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 23716398
SIC: 2834 Pharmaceutical Preparations